Product Catalog

SurvodutideSpecifications & Batch COA

GLP-1/glucagon receptor dual agonist. Investigated for obesity and metabolic-associated steatohepatitis (MASH).

KERUIHK-0108Survodutide product vial
Lyophilized PowderProduct image
Weight Loss & Metabolic

Survodutide

ResearchKERUIHK-0108

GLP-1/glucagon receptor dual agonist. Investigated for obesity and metabolic-associated steatohepatitis (MASH).

Product Specifications

CAS Number
2381609-38-5
Catalog Purity
≥99.36%
Form
Lyophilized Powder
Catalog Grade
Research
View batch documentation

Product Details

Survodutide specifications

Use the product name, catalog reference and available specifications below when discussing your requirements with our team.

Product
Survodutide
Catalog reference
KERUIHK-0108
CAS number
2381609-38-5
Category
Weight Loss & Metabolic
Physical form
Lyophilized Powder

Latest reported batch: Survodutide

Batch PB-2026-SUR-1182 · Oct 4, 2026

Reported appearance
White lyophilized powder
Reported molecular weight / identity
4398.95 Da
Analytical method
RP-HPLC / ESI-MS

Reported analytical results

HPLC Purity
99.03%Report specification: ≥99.0%
Molecular Weight (MS)
4398.95 DaReport specification: 4398.6 ± 0.5 Da
Amino Acid Analysis
ConformsReport specification: Conforms to sequence
Appearance
White lyophilized powderReport specification: White to off-white powder
Show 4 more test results
Solubility
Soluble in waterReport specification: Soluble in water (≥1 mg/mL)
Water Content (KF)
6.25%Report specification: ≤ 8.0%
Residual Solvents
< ICH Q3C limitsReport specification: ICH Q3C Class 2
Sterility (USP <71>)
No growth observedReport specification: No evidence of microbial growth
Source COA: PB-2026-SUR-1182-R20261004
Explore this category

Batch Documentation

Certificates of Analysis

Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.

PB-2026-SUR-1182Report product: SurvodutideOct 4, 2026 · Reported purity: 99.03%View this batch COA
PB-2026-SUR-1182Report product: SurvodutideSep 02, 2026 · Reported purity: 99.2%View this batch COA
PB-2026-SUR-0246Report product: SurvodutideJul 24, 2026 · Reported purity: 99.1%View this batch COA
Show 1 earlier reports
PB-2026-SUR-0087Report product: SurvodutideApr 21, 2026 · Reported purity: 99.0%View this batch COA

Product Inquiry

Request a Survodutide quotation

We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.

Discuss your requirements
Back to all products